Deciphera Pharmaceuticals DCPH 深 沪
等待开盘 09-09 09:30:00 美东时间
25.59
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 25.59
- 总市值 206.77万
- 52周最高 25.61
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 9.90
- 委 比 0.00%
- 总股本 8.08万
- 历史最高 71.11
- 量 比 0
- 振 幅 0.00%
- 历史最低 6.51
- 每 手 1
- 风险率 4.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Replimune Reports Fiscal First Quarter 2027 Financial Results and Provides Corporate Update
Replimune Group announced the FDA accelerated approval of TUDRIQEV™ in combination with nivolumab for advanced melanoma, with U.S. launch expected within 60 days. The company secured $150 million in financing to support commercialization and the IGNYTE-3 confirmatory trial. Michelle DiNapoli was appointed Chief Commercial Officer, bringing extensive oncology experience. Replimune reported a cash balance of $195.3 million as of June 30, 2026, and ...
08-14 12:00
MBX Biosciences Announces Executive Leadership Transition to Support the Company’s Next Phase of Growth
MBX Biosciences announces leadership changes: Steve Hoerter appointed as CEO, replacing Kent Hawryluk, and John Smither as CFO. Hoerter, a biotech veteran, succeeds Hawryluk, who co-founded the company and led its growth. The company remains focused on advancing precision peptide therapies for endocrine and metabolic disorders, with key milestones expected in 2026.
07-13 20:15
J.P. Morgan Life Sciences Private Capital Welcomes Dashyant Dhanak, Ph.D. as Venture Partner
NEW YORK, May 19, 2025 /PRNewswire/ -- J.P. Morgan Life Sciences Private Capital, the life sciences venture and growth equity arm within J.P. Morgan Asset Management, today announced the app...
2025-05-19 22:00
Ono Pharmaceutical completes tender offer for Deciphera
Ono Pharmaceutical has successfully completed its $2.4B tender offer for Deciphera Pharmaceuticals (NASDAQ:DCPH). As a result of the transaction, Deciphera is now a wholly owned subsidiary of Ono, wit...
2024-06-11 22:22
Deciphera Pharmaceuticals: Significant Post-Merger Corporate Changes
An update from Deciphera Pharmaceuticals (DCPH) is now available. Following the...
2024-06-11 21:59
Kuehn Law Encourages HIBB, CRGY, DCPH, and HCP Investors to Contact Law Firm
NEW YORK, June 3, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek...
2024-06-04 01:07
